Cited 0 times in
The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 오영택 | - |
dc.date.accessioned | 2015-04-24T17:44:56Z | - |
dc.date.available | 2015-04-24T17:44:56Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/105994 | - |
dc.description.abstract | Medical applications of nanoparticular systems have attracted considerable attention because of their potential use in therapeutic targeting of disease tissues and their lower level of toxicity against healthy tissue, relative to traditional pharmaceutical drugs. The use of nanoparticular systems has been shown to overcome the limitations of most anticancer drugs in clinical applications. In particular, the improved performance of smarted nanoparticular system for solving the drug resistance problems that typically interrupt tumor treatment has provided a promising strategy for successful tumor chemotherapy. This review highlights recent studies that have examined the therapeutic effect of nanoparticular systems on drug-resistant tumors and presents insight on how they work | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 3776~3792 | - |
dc.language | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.publisher | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antineoplastic Agents/administration & dosage* | - |
dc.subject.MESH | Antineoplastic Agents/chemistry* | - |
dc.subject.MESH | Antineoplastic Agents/pharmacology | - |
dc.subject.MESH | Antineoplastic Agents/therapeutic use | - |
dc.subject.MESH | Doxorubicin/chemistry | - |
dc.subject.MESH | Doxorubicin/pharmacology | - |
dc.subject.MESH | Doxorubicin/therapeutic use | - |
dc.subject.MESH | Drug Resistance, Neoplasm* | - |
dc.subject.MESH | Drug Screening Assays, Antitumor | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Nanocapsules/chemistry* | - |
dc.subject.MESH | Nanocapsules/therapeutic use | - |
dc.subject.MESH | Neoplasms/drug therapy* | - |
dc.subject.MESH | Neoplasms/pathology | - |
dc.subject.MESH | Tumor Microenvironment/drug effects | - |
dc.title | The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Radiology (영상의학) | - |
dc.contributor.googleauthor | Kyung Taek Oh | - |
dc.contributor.googleauthor | Hye Jung Baik | - |
dc.contributor.googleauthor | A Hyeong Lee | - |
dc.contributor.googleauthor | Young Taik Oh | - |
dc.contributor.googleauthor | Yu Seok Youn | - |
dc.contributor.googleauthor | Eun Seong Lee | - |
dc.identifier.doi | 10.3390/ijms10093776 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02390 | - |
dc.relation.journalcode | J01133 | - |
dc.identifier.eissn | 1422-0067 | - |
dc.identifier.pmid | 19865518 | - |
dc.subject.keyword | drug delivery system | - |
dc.subject.keyword | multi-drug resistance | - |
dc.subject.keyword | nanoparticle | - |
dc.subject.keyword | tumor treatment | - |
dc.contributor.alternativeName | Oh, Young Taik | - |
dc.contributor.affiliatedAuthor | Oh, Young Taik | - |
dc.citation.volume | 10 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 3776 | - |
dc.citation.endPage | 3792 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Vol.10(9) : 3776-3792, 2009 | - |
dc.identifier.rimsid | 51499 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.